Delivery Order SPE2DB22D2006-SPE2DB24FV8DU
- Not listed
- This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $16,182.64 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of September 19, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $14,550.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TIVICAY 50 MG TABLET 30S. The contract, a Delivery Order with a Firm Fixed Price, has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical supplier of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $82,294.68 for the supply of TIVICAY 50 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company...
- This federal contract award, valued at $5,310.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 15, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
- This contract award, valued at $20,596.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of May 19, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TIVICAY 50 MG TABLET 30S. The fixed-price delivery order, valued at $33,068.24, has a completion date of May 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,861.66 firm fixed-price contract is for the delivery of 4562122502 - TIVICAY 50 MG TABLET 30S, with a performance period ending on September 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company...
- This federal contract award with a value of $25,445.00 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order for the provision of 4563415624 - TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order with a ceiling value of $13,191.34, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a medication, with a performance period ending on April 18, 2023. The contract is a firm fixed-price arrangement and was awarded on April 17, 2023, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent...
- This federal contract award, valued at $35,728.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with any set-aside designation, indicating it was awarded through full and open competition....
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8DUDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $41,667.43, is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 15, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.7k | 2/14/24 |